PureTech Health (PRTC) Competitors $16.93 +0.18 (+1.07%) Closing price 04/17/2025 03:51 PM EasternExtended Trading$16.63 -0.30 (-1.77%) As of 04/17/2025 04:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PRTC vs. GLPG, BHC, CNTA, AGIO, ARQT, CGON, KNSA, APGE, IDYA, and ANIPShould you be buying PureTech Health stock or one of its competitors? The main competitors of PureTech Health include Galapagos (GLPG), Bausch Health Companies (BHC), Centessa Pharmaceuticals (CNTA), Agios Pharmaceuticals (AGIO), Arcutis Biotherapeutics (ARQT), CG Oncology (CGON), Kiniksa Pharmaceuticals (KNSA), Apogee Therapeutics (APGE), IDEAYA Biosciences (IDYA), and ANI Pharmaceuticals (ANIP). These companies are all part of the "pharmaceutical products" industry. PureTech Health vs. Galapagos Bausch Health Companies Centessa Pharmaceuticals Agios Pharmaceuticals Arcutis Biotherapeutics CG Oncology Kiniksa Pharmaceuticals Apogee Therapeutics IDEAYA Biosciences ANI Pharmaceuticals Galapagos (NASDAQ:GLPG) and PureTech Health (NASDAQ:PRTC) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their community ranking, risk, media sentiment, dividends, institutional ownership, earnings, analyst recommendations, profitability and valuation. Which has higher valuation and earnings, GLPG or PRTC? Galapagos has higher revenue and earnings than PureTech Health. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGalapagos$275.65M5.93$80.16MN/AN/APureTech Health$3.33M121.14-$65.70MN/AN/A Is GLPG or PRTC more profitable? Company Net Margins Return on Equity Return on Assets GalapagosN/A N/A N/A PureTech Health N/A N/A N/A Does the media refer more to GLPG or PRTC? In the previous week, Galapagos had 7 more articles in the media than PureTech Health. MarketBeat recorded 9 mentions for Galapagos and 2 mentions for PureTech Health. PureTech Health's average media sentiment score of 0.79 beat Galapagos' score of 0.50 indicating that PureTech Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Galapagos 3 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral PureTech Health 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, GLPG or PRTC? Galapagos has a beta of 0.16, suggesting that its share price is 84% less volatile than the S&P 500. Comparatively, PureTech Health has a beta of 1.12, suggesting that its share price is 12% more volatile than the S&P 500. Does the MarketBeat Community favor GLPG or PRTC? Galapagos received 457 more outperform votes than PureTech Health when rated by MarketBeat users. Likewise, 63.84% of users gave Galapagos an outperform vote while only 45.00% of users gave PureTech Health an outperform vote. CompanyUnderperformOutperformGalapagosOutperform Votes46663.84% Underperform Votes26436.16% PureTech HealthOutperform Votes945.00% Underperform Votes1155.00% Do institutionals & insiders have more ownership in GLPG or PRTC? 32.5% of Galapagos shares are held by institutional investors. Comparatively, 0.0% of PureTech Health shares are held by institutional investors. 2.9% of Galapagos shares are held by company insiders. Comparatively, 5.3% of PureTech Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Do analysts prefer GLPG or PRTC? Galapagos currently has a consensus target price of $25.33, suggesting a potential upside of 2.09%. PureTech Health has a consensus target price of $45.00, suggesting a potential upside of 167.94%. Given PureTech Health's stronger consensus rating and higher possible upside, analysts plainly believe PureTech Health is more favorable than Galapagos.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Galapagos 4 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50PureTech Health 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 SummaryPureTech Health beats Galapagos on 8 of the 14 factors compared between the two stocks. Get PureTech Health News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRTC vs. The Competition Export to ExcelMetricPureTech HealthPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$403.40M$6.48B$5.30B$7.37BDividend YieldN/A3.24%5.11%4.31%P/E RatioN/A6.8621.7117.79Price / Sales121.14230.18378.3096.40Price / CashN/A65.6738.1534.64Price / Book0.995.906.433.98Net Income-$65.70M$142.26M$3.20B$247.33M7 Day Performance24.59%7.69%4.86%4.34%1 Month Performance-6.63%-14.07%-9.80%-7.83%1 Year Performance-37.65%-10.22%10.77%1.29% PureTech Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRTCPureTech Health2.8308 of 5 stars$16.93+1.1%$45.00+165.8%-37.1%$406.64M$3.33M0.00100Upcoming EarningsShort Interest ↓GLPGGalapagos0.6546 of 5 stars$24.20+0.8%$25.33+4.7%-15.6%$1.59B$275.65M0.001,310Upcoming EarningsHigh Trading VolumeBHCBausch Health Companies4.0825 of 5 stars$4.33+0.2%$7.17+65.5%-40.8%$1.59B$9.63B-36.0819,900Short Interest ↑CNTACentessa Pharmaceuticals2.9316 of 5 stars$11.94+3.2%$27.71+132.1%+14.1%$1.59B$6.85M-7.80200Gap DownAGIOAgios Pharmaceuticals3.8711 of 5 stars$27.52+3.1%$56.57+105.6%-4.7%$1.58B$36.50M2.43390Analyst RevisionARQTArcutis Biotherapeutics2.9241 of 5 stars$12.94+2.8%$18.80+45.3%+26.9%$1.54B$196.54M-7.23150Gap UpCGONCG Oncology1.109 of 5 stars$20.06+4.0%$63.88+218.4%-43.3%$1.53B$1.14M-14.1361Analyst ForecastGap DownKNSAKiniksa Pharmaceuticals2.425 of 5 stars$20.69+7.1%$37.17+79.6%+19.2%$1.50B$423.24M-147.78220Upcoming EarningsAnalyst ForecastInsider TradeNews CoveragePositive NewsGap DownAPGEApogee Therapeutics2.0773 of 5 stars$33.28+4.7%$92.17+176.9%-35.7%$1.50BN/A-13.7591IDYAIDEAYA Biosciences3.5552 of 5 stars$17.11+2.1%$53.58+213.2%-57.5%$1.50B$7M-5.1880Positive NewsGap UpANIPANI Pharmaceuticals3.6208 of 5 stars$68.72+0.9%$79.75+16.1%+5.7%$1.50B$614.38M-124.95600Analyst UpgradeNews CoveragePositive News Related Companies and Tools Related Companies GLPG Alternatives BHC Alternatives CNTA Alternatives AGIO Alternatives ARQT Alternatives CGON Alternatives KNSA Alternatives APGE Alternatives IDYA Alternatives ANIP Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PRTC) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PureTech Health plc Please log in to your account or sign up in order to add this asset to your watchlist. Share PureTech Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.